MUSTAFA MOHAMMED MOAZAM

Allopathic & Osteopathic Physicians|Internal Medicine EL PASO, TX NPI 1306987474

General Payments — all program years on this page

$3,256.28

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 202
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $623.50 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $596.2321
Education $27.271

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $381.9728
2019 $719.5463
2020 $188.1412
2021 $493.9615
2022 $322.2532
2023 $526.9230
2024 $623.5022

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078199395 Janssen Pharmaceuticals, Inc $17.23 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078199523 Janssen Pharmaceuticals, Inc $16.97 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086160944 Bayer Healthcare Pharmaceuticals Inc. $28.89 07/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101240774 E.R. Squibb & Sons, L.L.C. $27.27 12/04/2024 Education Undisputed 01/23/2026 View at CMS
1104373235 AstraZeneca Pharmaceuticals LP $13.23 07/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105048600 ABBVIE INC. $13.12 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105048602 ABBVIE INC. $31.49 08/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105048604 ABBVIE INC. $27.55 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105048606 ABBVIE INC. $34.54 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114533887 Exact Sciences Corporation $14.44 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117958532 Boehringer Ingelheim Pharmaceuticals, Inc. $22.43 07/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117958534 Boehringer Ingelheim Pharmaceuticals, Inc. $29.61 05/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133077086 Genentech USA, Inc. $24.53 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133077090 Genentech, Inc. $147.88 12/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135175149 Lilly USA, LLC $13.75 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135211099 Lilly USA, LLC $19.90 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135227641 Lilly USA, LLC $20.52 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135257038 Lilly USA, LLC $14.30 08/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137636956 Takeda Pharmaceuticals U.S.A., Inc. $16.30 07/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139278906 Astellas Pharma US Inc $23.64 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139752079 GENZYME CORPORATION $26.07 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147391044 X4 Pharmaceuticals, Inc. $39.84 12/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.